Valo Therapeutics is a series b startup. 1 investor tracked. Status: possibledead.
Valo Therapeutics is a startup based in Finland. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Valo Therapeutics is a biopharmaceutical company developing novel cancer immunotherapies based on its patented platform technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.